Envision Healthcare Corporation (NYSE:EVHC) had its price target decreased by equities researchers at Oppenheimer Holdings, Inc. from $77.00 to $40.00 in a report issued on Thursday, November 2nd. The brokerage currently has an “outperform” rating on the stock. Oppenheimer Holdings, Inc.’s price objective suggests a potential upside of 33.33% from the stock’s current price.
Several other analysts also recently weighed in on EVHC. Bank of America Corporation dropped their target price on shares of Envision Healthcare Corporation from $72.00 to $60.00 and set a “buy” rating for the company in a report on Monday, October 9th. Citigroup Inc. downgraded shares of Envision Healthcare Corporation from a “buy” rating to a “neutral” rating and set a $31.00 target price for the company. in a report on Thursday, November 2nd. Mizuho set a $57.00 target price on shares of Envision Healthcare Corporation and gave the company a “hold” rating in a report on Tuesday, October 31st. SunTrust Banks, Inc. set a $55.00 price target on shares of Envision Healthcare Corporation and gave the company a “buy” rating in a research report on Sunday, October 15th. Finally, KeyCorp decreased their price target on shares of Envision Healthcare Corporation from $67.00 to $37.00 and set an “overweight” rating for the company in a research report on Thursday, November 2nd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $47.57.
Shares of Envision Healthcare Corporation (EVHC) opened at $30.00 on Thursday. The stock has a market cap of $3,504.58, a PE ratio of 8.95, a PEG ratio of 0.75 and a beta of 0.69. Envision Healthcare Corporation has a 12 month low of $23.77 and a 12 month high of $74.75. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01.
Envision Healthcare Corporation (NYSE:EVHC) last released its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). The business had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $2.03 billion. Envision Healthcare Corporation had a positive return on equity of 4.88% and a negative net margin of 6.39%. The company’s revenue for the quarter was up 142.0% compared to the same quarter last year. During the same period last year, the business earned $1.13 earnings per share. research analysts predict that Envision Healthcare Corporation will post 2.57 earnings per share for the current year.
Envision Healthcare Corporation declared that its Board of Directors has authorized a stock repurchase program on Monday, September 18th that authorizes the company to buyback $250.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase up to 4.5% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s management believes its stock is undervalued.
TRADEMARK VIOLATION WARNING: “Oppenheimer Holdings, Inc. Lowers Envision Healthcare Corporation (EVHC) Price Target to $40.00” was reported by BBNS and is the sole property of of BBNS. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://baseballnewssource.com/markets/oppenheimer-holdings-inc-trims-envision-healthcare-corporation-evhc-target-price-to-40-00/1753257.html.
A number of institutional investors and hedge funds have recently modified their holdings of the business. Exane Derivatives purchased a new stake in shares of Envision Healthcare Corporation in the third quarter valued at about $475,000. Honeywell International Inc. lifted its holdings in shares of Envision Healthcare Corporation by 17.4% in the third quarter. Honeywell International Inc. now owns 542,100 shares of the company’s stock valued at $24,367,000 after purchasing an additional 80,200 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its holdings in shares of Envision Healthcare Corporation by 5.6% in the second quarter. Schwab Charles Investment Management Inc. now owns 632,195 shares of the company’s stock valued at $39,620,000 after purchasing an additional 33,587 shares in the last quarter. Stonebridge Capital Management Inc. lifted its holdings in shares of Envision Healthcare Corporation by 87.0% in the third quarter. Stonebridge Capital Management Inc. now owns 30,329 shares of the company’s stock valued at $1,364,000 after purchasing an additional 14,111 shares in the last quarter. Finally, Nomura Holdings Inc. purchased a new stake in shares of Envision Healthcare Corporation in the second quarter valued at about $797,000.
Envision Healthcare Corporation Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with our FREE daily email newsletter.